AMS (American Medical Systems) closes TherMatrx deal:
This article was originally published in Clinica
Executive Summary
American Medical Systems (AMS) has completed its acquisition of TherMatrx, the developer of TMx2000, an in-office treatment for benign prostatic hyperplasia. The technology was originally developed by BSD Medical, a Salt Lake City company with substantial holdings in TherMatrx. AMS of Minnetonka, Minnesota, first announced its intention to purchase TherMatrx, which includes all of BSD's holdings in the company, in June (see Clinica No 1113, p 13).